Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term Bacterial and host surface proteins refers to a broad and heterogeneous category of proteins located on the exterior membranes of both bacterial pathogens and their respective host cells. These proteins play critical roles in the initial stages of infection, including bacterial adhesion, colonization, and invasion of host tissues. On the bacterial side, these include adhesins, invasins, and secretion systems, while host surface proteins often include receptors, integrins, and glycoproteins that are exploited by pathogens for entry. Because this term encompasses thousands of distinct proteins with diverse structures and functions, it does not represent a single, well-defined therapeutic target. In drug development, specific proteins within this category, such as Penicillin-binding proteins in bacteria or CCR5 in humans, are targeted individually to achieve therapeutic efficacy.
Not applicable as this is a broad category of proteins rather than a specific therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial and host surface proteins.